Jay Mehta retweeted
At 12, Molly’s ankle injury became months of pain and uncertainty before she was diagnosed with Juvenile Idiopathic Arthritis. With her family’s support, she found remission and became an advocate for others. LISTEN → acr.tw/4gVAEjc
Jay Mehta retweeted
⏰ It's time to apply for the CARRA-@ArthritisFdn Intramural grants! Jan. 15th is the deadline for Letters of Intent (LOIs) for Registry and Biobank-related RFAs for the CARRA-AF grants.
✅ Check out all the grant opportunities and the RFAs here 👉🏼 tinyurl.com/yck2s968
Jay Mehta retweeted
🗨️ Improving JIA outcomes and reducing disparities is challenging, yet we demonstrate that it is feasible using an equity-driven approach"
Healio talked with @DrDNAbel about what her group has learned at @ChildrensPhila👇
healio.com/news/rheumatology…
Jay Mehta retweeted
So grateful for this opportunity from @AcademyHealth and @MooreFound to improve diagnosis for kiddos with rheumatic diseases (and excited to learn more from @UCSF_CoDEx)!!
This Post is from an account that no longer exists. Learn more
Jay Mehta retweeted
🙌 Congratulations to @Annatomiga of @ChildrensPhila! Dr. Costello is the winner of a CARRA-@ArthritisFdn Mentored Career Development Award for her research entitled “Defining and Characterizing Diagnostic Delay in Juvenile Idiopathic Arthritis.”🌟#kidsgetarthritistoo #pedsrheum
Jay Mehta retweeted
Are you in #meded #hpe & looking for qualitative research training? Specifically on reflexive thematic analysis and narrative analysis?
Yes?
Come join @dorenebalmer @AKonopasky, Emiko Blalock & I @ChildrensPhila on 4/15 for a full day workshop
Register: bit.ly/3TFaK7V
Jay Mehta retweeted
CARRA Early Investigators and Fellows:
Looking for a way to fit more focused academic writing time into your week? Sign up for a slot in a #carra Writing Accountability Group (WAG) here: redcap.link/3eeungi6
Groups of #pedsrheum writers will start meeting this spring!
Jay Mehta retweeted
Agree, great job @DrDNAbel! She def pulled some punches. This is a big issue that #PBMs have fought to silence - ppl should be livid, esp in #RareDisease community.
Why do PBM exist? ...
Very proud of @ChildrensPhila #pedsrheum fellow @DrDNAbel for this beautifully written letter in@PhillyInquirer about the absolutely unconscionable rigamarole that is insurance prior authorization.
inquirer.com/opinion/comment…
@ACRheum
@ACRheumDC
@carrainc
Jay Mehta retweeted
🦓#RareDiseaseDay is close to our heart because CARRA was founded by peds rheumatologists who realized that the only way to advance research in rare pediatric rheumatic diseases was to create a collaborative network and work together. 💙
#Showyourstripes @RareDiseases
Jay Mehta retweeted
Check out "The Future Looks Bright: Managing PsO and PsA in Youth" episode of the Psound Bytes Podcast, as #ClinicalFutures' Associate Director of Clinical Trials, Dr. Pamela Weiss, discusses the latest research surrounding #psoriaticdisease: apple.co/4bF1ybV
Jay Mehta retweeted
Calling early investigators and #pedsrheum researchers interested in @carrainc
@ArthritisFdn grants- the deadline for CARRA Registry data/sample share requests has been extended to Mon Feb 5!
Data request form: carra.tfaforms.net/34
More about grants: carragroup.org/research/gran…
Jay Mehta retweeted
⏰ It’s time to apply for the CARRA-Arthritis Foundation Intramural Grants!
➡️ Check out all of the amazing opportunities here: carragroup.org/research/gran… and apply here: carragroup.org/research/appl…
#pedsrheum #rheumatology #researchopportunity #HealthEquity
Jay Mehta retweeted
New Jersey rheums, join the ACR and our friends @MSNJ1766 in supporting A1255 prior authorization reform in New Jersey. It is time to remove the access barriers created by prior authorization. Patients deserve better. Together, let's make a difference! acr.tw/47hnJ5i
Jay Mehta retweeted
Team effort with @sandy_burnham and #pedsrheum colleagues @ChildrensPhila @jaymehtamd @SabrinaGmucaMD
What is the pLCI & how did podcast guest @JoyceChangMD encourage its adoption in the #pedsrheum community? Plus, how she developed a population management strategy for young people with #lupusnephritis. Listen → acrjournalsonair.org @ACR_Journals
Jay Mehta retweeted
Also check out the @BostonChildrens screening algorithm: acrjournals.onlinelibrary.wi…
Jay Mehta retweeted
Credit an amazing community of #SJIALD families, who have come together amazingly and admirably. They have no better advocates @GrantSchulert
"Disease course, tx, & outcomes in SJIA-LD) acrjournals.onlinelibrary.wi…
Jay Mehta retweeted
🚨 AMIGO applications are open!
There’s a new look to the program this year, and we encourage all #pedsrheum to apply.
AMIGO, the ACR/@carrainc Mentoring Interest Group, is now accepting applications for #pedsrheum mentors & mentees. Deadline to apply is Friday, Sept. 8. ACR membership is required to participate. Learn more → acr.tw/47LGD55
Jay Mehta retweeted
We know you're struggling with those challenging/crucial early decisions in #HLH / #MAS.
We are too, so we're pleased to finally present:
"The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected HLH/MAS"
doi.org/10.1002/art.42636
Jay Mehta retweeted
Patients with childhood systemic #lupus erythematosus who receive care that closely adheres to quality metrics demonstrate better outcomes, @JoyceChangMD told Healio #RheumTwitter
bit.ly/3JzlP6e
Jay Mehta retweeted
Due to unexpected circumstances, we have an urgent need to fill a first year Pediatric Rheumatology fellow position @MontefiorePeds. Please see below and share!
